Study of Camrelizumab (SHR-1210) in Combination With Concurrent Chemoradiotherapy in Locally Advanced Esophageal Cancer
Clinical trial NCT04426955 · UNKNOWN
Trial details
- NCT number
- NCT04426955
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-30
- Primary completion
- 2022-12-01
- Enrollment
- 396
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.